Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 in resistant hypertension with vitamin D insufficiency
2008-002681-63Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vitamin d in resistant hypertension (RH), sponsored by University of Dundee. Primary endpoint: Change in mean 24-hour systolic blood pressure at 6 months. Started Jul 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on 2008-002681-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002681-63.